Press releases //

IntegraGen and GoPath Laboratories sign licensing agreement for miR-31-3p test in North America

IntegraGen and GoPath Laboratories announced today the signing of a non-exclusive licensing agreement allowing GoPath to develop and provide a test based on IntegraGen’s proprietary miR-31-3p biomarker to physicians in the United States and Canada. The test will complement GoPath’s specialized molecular diagnostic testing portfolio for cancer and enable clinicians to (…)  » 

Press releases //

IntegraGen to attend the Jefferies 2017 London Healthcare Conference

IntegraGen will participate in The Jefferies 2017 London Healthcare Conference taking place 15 and 16 November 2017 in London, UK.

The Jefferies Conference is the largest healthcare-dedicated conference in Europe with over 350 participating companies, 1,400 attendees and 3,400 business-to-business and investor meetings. The event will feature (…)  »